<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    111, Inc.

    verified_userVerify Profile
    Companies » Consumer Services » Food & Drug Retailers » Drug Retailers

    About 111, Inc.

    111,Inc., co-founded by Gang Yu and Junling Liu in 2010, is a leading digital and mobile healthcare platform in China. By applying advanced Internet and information technology, 111,Inc. is devoted to online medical services and online pharmacy through optimized supply chain and cloud services, to increase the efficiency and transparency of drug retail and distribution. 111,Inc. aims to deliver the best and comprehensive healthcare solutions to Chinese people. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $2,300,000,000
    • SIC CODE
      5912
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Gang Yu and Junling Liu
    • FOUNDED
      2010
    • EMPLOYEES
      1001-5000
    • SECTOR
      Food & Drug Retailers
    • SUBSECTOR
      Drug Retailers

    Company Tags

    No articles found.

    PLx Pharma Inc.

    PLx Pharma Inc.

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage specialty pharmaceutical company i...

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage...

    Filing Type:    PU
    Aytu BioScience, Inc.

    Aytu BioScience, Inc.

    Aytu is committed to better health for men and women here at home and worldwide. W...

    Aytu is committed to better health for men and ...

    Filing Type:    PU
    MediciNova, Inc.

    MediciNova, Inc.

    MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiri...

    MediciNova, Inc. is a publicly-traded biopharma...

    Filing Type:    PU
    NowRx, Inc.

    NowRx, Inc.

    NowRx provides a trusted, reliable way to have your prescriptions delivered, from ...

    NowRx provides a trusted, reliable way to have ...

    Amount Raised:    $2,233,127.00
    Fundraising Status:    EC
    Filing Type:    RACF
    Fred's, Inc.

    Fred's, Inc.

    Tracing our history back to an original store in Coldwater, Mississippi in 1947, F...

    Tracing our history back to an original store i...

    Filing Type:    PU
    China Jo-Jo Drugstores, Inc.

    China Jo-Jo Drugstores, Inc.

    Incorporated in 2006 with headquarters in Hangzhou, China, China Jo-Jo Drugstores,...

    Incorporated in 2006 with headquarters in Hangz...

    Filing Type:    PU
    Comic Blitz LLC

    Comic Blitz LLC

    ComicBlitz is focused in streaming digital comic books, providing an all-you-can-r...

    ComicBlitz is focused in streaming digital comi...

    Amount Raised:    $87,810
    Fundraising Status:    SD
    Filing Type:    CF
    Dropbox, Inc.

    Dropbox, Inc.

    Dropbox is a leading global collaboration platform that's transforming the way peo...

    Dropbox is a leading global collaboration platf...

    Filing Type:    PU
    Narrative Company

    Narrative Company

    We are building a publishing platform with a built in revenue model. Content is cr...

    We are building a publishing platform with a bu...

    Amount Raised:    $0.00
    Fundraising Status:    EC
    Filing Type:    CF
    Avinger, Inc.

    Avinger, Inc.

    Avinger is a commercial-stage medical device company that designs, manufactures an...

    Avinger is a commercial-stage medical device co...

    Filing Type:    PU
    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrate...

    Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a Sa...

    Filing Type:    PU
    Beta Bionics, Inc.

    Beta Bionics, Inc.

    Beta Bionics develops an integrated bionic pancreas system called the iLet.

    Beta Bionics develops an integrated bionic panc...

    Amount Raised:    $126,600,000
    Fundraising Status:    SB
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.